Cancer screening in the United States, 2016: A review of current American Cancer Society guidelines and current issues in cancer screening

Answer questions and earn CME/CNE

[1]  M. Yaffe,et al.  American Cancer Society Guidelines for Breast Screening with MRI as an Adjunct to Mammography , 2007, CA: a cancer journal for clinicians.

[2]  Perry J Pickhardt,et al.  Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps, 2008: A Joint Guideline from the American Cancer Society, the US Multi‐Society Task Force on Colorectal Cancer, and the American College of Radiology * † , 2008, CA: a cancer journal for clinicians.

[3]  Yi Li,et al.  Tumor markers for early detection of ovarian cancer , 2010, Expert review of molecular diagnostics.

[4]  American society for colposcopy and cervical pathology. , 1997, Journal of lower genital tract disease.

[5]  G. Guyatt,et al.  GRADE guidelines: 1. Introduction-GRADE evidence profiles and summary of findings tables. , 2011, Journal of clinical epidemiology.

[6]  Screening for Cervical Cancer: US Preventive Services Task Force Recommendation Statement , 2018, Obstetrical & Gynecological Survey.

[7]  Robert H Fletcher,et al.  Guidelines for colonoscopy surveillance after polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer and the American Cancer Society. , 2006, CA: a cancer journal for clinicians.

[8]  W. P. Evans,et al.  American Cancer Society Guidelines for Breast Cancer Screening: Update 2003 , 2003, CA: a cancer journal for clinicians.

[9]  Patrick Neven,et al.  Endometrial cancer. , 2005, Lancet.

[10]  L. Tabár,et al.  Insights from the Breast Cancer Screening Trials: How Screening Affects the Natural History of Breast Cancer and Implications for Evaluating Service Screening Programs , 2015, The breast journal.

[11]  D. Berry,et al.  Benefits and harms of CT screening for lung cancer: a systematic review. , 2012, JAMA.

[12]  V. Moyer.  Screening for Lung Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2014, Annals of Internal Medicine.

[13]  T. Enomoto,et al.  Biomarkers for Screening, Diagnosis, and Monitoring of Ovarian Cancer , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[14]  L. Esserman,et al.  Genetic/familial high-risk assessment , 2010 .

[15]  D. Lieberman,et al.  Accuracy of Screening for Fecal Occult Blood on a Single Stool Sample Obtained by Digital Rectal Examination: A Comparison with Recommended Sampling Practice , 2005, Annals of Internal Medicine.

[16]  Harminder Singh,et al.  Rate and Predictors of Early/Missed Colorectal Cancers After Colonoscopy in Manitoba: A Population-Based Study , 2010, The American Journal of Gastroenterology.

[17]  N. Dubrawsky.  Cancer statistics , 1989, CA: a cancer journal for clinicians.

[18]  N Risch,et al.  Autosomal dominant inheritance of early‐onset breast cancer. Implications for risk prediction , 1994, Cancer.

[19]  A. Moscicki,et al.  American Cancer Society Guideline for the Early Detection of Cervical Neoplasia and Cancer , 2002, CA: a cancer journal for clinicians.

[20]  P. Maisonneuve,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps. , 2008, Gastroenterology.

[21]  Ovarian cancer: Screening, treatment, and follow‐up , 1995 .

[22]  E. Unger,et al.  Human papillomavirus vaccination: recommendations of the Advisory Committee on Immunization Practices (ACIP). , 2014, MMWR. Recommendations and reports : Morbidity and mortality weekly report. Recommendations and reports.

[23]  D. Ransohoff,et al.  New American Cancer Society process for creating trustworthy cancer screening guidelines. , 2011, JAMA.

[24]  V. Shavers,et al.  Perceived Cancer Risk: Why Is It Lower Among Nonwhites than Whites? , 2010, Cancer Epidemiology, Biomarkers & Prevention.

[25]  T. Reynolds,et al.  The role of CA125 in clinical practice , 2005, Journal of Clinical Pathology.

[26]  Philadelphia County,et al.  Human Papillomavirus Vaccination Coverage Among Adolescent Girls, 2007-2012, and Postlicensure Vaccine Safety Monitoring, 2006-2013 — United States , 2013 .

[27]  Christi J. van Asperen,et al.  Differences and similarities in breast cancer risk assessment models in clinical practice: which model to choose? , 2009, Breast Cancer Research and Treatment.

[28]  D. Miglioretti,et al.  Biennial versus annual mammography and the risk of late-stage breast cancer. , 2004, Journal of the National Cancer Institute.

[29]  Timothy J Wilt,et al.  Screening for breast cancer: U.S. Preventive Services Task Force recommendation statement. , 2009, Annals of internal medicine.

[30]  Jay Parikh,et al.  Impact of mammography detection on the course of breast cancer in women aged 40-49 years. , 2012, Radiology.

[31]  Gerald Gartlehner,et al.  [GRADE guidelines 15: going from evidence to recommendation - determinants of a recommendation's direction and strength]. , 2014, Zeitschrift fur Evidenz, Fortbildung und Qualitat im Gesundheitswesen.

[32]  Robert A. Smith,et al.  American Cancer Society Guidelines for the Early Detection of Cancer, 2003 , 2003, CA: a cancer journal for clinicians.

[33]  M. Schiffman,et al.  American Cancer Society, American Society for Colposcopy and Cervical Pathology, and American Society for Clinical Pathology screening guidelines for the prevention and early detection of cervical cancer , 2012, CA: a cancer journal for clinicians.

[34]  R. Smith,et al.  Breast cancer screening guidelines. , 1992, Women's health issues : official publication of the Jacobs Institute of Women's Health.

[35]  E. Pisano,et al.  Consequences of false-positive screening mammograms. , 2014, JAMA internal medicine.

[36]  Randall W Burt,et al.  Guidelines on genetic evaluation and management of Lynch syndrome: a consensus statement by the US Multi-Society Task Force on Colorectal Cancer. , 2014, Diseases of the colon and rectum.

[37]  T. Pawlik,et al.  US Preventive Services Task Force. Screening for breast cancer: US Preventive Task Force recommendation statement , 2013 .

[38]  Charles J. Kahi,et al.  Guidelines for Colonoscopy Surveillance after Cancer Resection: A Consensus Update by the American Cancer Society and US Multi‐Society Task Force on Colorectal Cancer * † , 2006, CA: a cancer journal for clinicians.

[39]  G. Colditz,et al.  Online Continuing Education Activity Article Title: American Cancer Society Lung Cancer Screening Guidelines Continuing Medical Education Accreditation and Designation Statement: Continuing Nursing Education Accreditation and Designation Statement: Educational Objectives: Activity Disclosures Acs Co , 2022 .

[40]  Elie A Akl,et al.  GRADE guidelines: 14. Going from evidence to recommendations: the significance and presentation of recommendations. , 2013, Journal of clinical epidemiology.

[41]  Giovanni Parmigiani,et al.  Meta-analysis of BRCA1 and BRCA2 penetrance. , 2007, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[42]  Brian Drohan,et al.  Which Risk Model to Use? Clinical Implications of the ACS MRI Screening Guidelines , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[43]  C. Schairer,et al.  Twenty-five Years of Breast Cancer Risk Models and Their Applications , 2015 .

[44]  D. Miglioretti,et al.  Risk of less-favorable breast tumor characteristics with biennial versus annual mammography by age and menopausal status , 2015 .

[45]  Douglas K. Rex,et al.  Quality Indicators for Colonoscopy , 2006, Gastrointestinal endoscopy.

[46]  A. Jensen,et al.  Late effects of breast cancer treatment and potentials for rehabilitation , 2011, Acta oncologica.

[47]  Muhammad F Dawwas,et al.  Adenoma detection rate and risk of colorectal cancer and death. , 2014, The New England journal of medicine.

[48]  T. Johnson,et al.  Accuracy of Self-Reported Cancer-Screening Histories: A Meta-analysis , 2008, Cancer Epidemiology Biomarkers & Prevention.

[49]  K. Matthews,et al.  Factors related to age at natural menopause: longitudinal analyses from SWAN. , 2013, American journal of epidemiology.

[50]  E. J. Mayeaux,et al.  Use of primary high-risk human papillomavirus testing for cervical cancer screening: interim clinical guidance. , 2015, Gynecologic oncology.

[51]  L. Tanoue,et al.  Reduced lung cancer mortality with low-dose computed tomographic screening , 2011 .

[52]  H. Pohl,et al.  Colorectal cancers detected after colonoscopy frequently result from missed lesions. , 2010, Clinical gastroenterology and hepatology : the official clinical practice journal of the American Gastroenterological Association.

[53]  M. Duffy,et al.  CA125 in ovarian cancer: European Group on Tumor Markers guidelines for clinical use , 2004, International Journal of Gynecologic Cancer.

[54]  V. Moyer,et al.  Screening for Cervical Cancer: U.S. Preventive Services Task Force Recommendation Statement , 2012, Annals of Internal Medicine.

[55]  U. P. S. T. Force.  Screening for Testicular Cancer: U.S. Preventive Services Task Force Reaffirmation Recommendation Statement , 2011, Annals of Internal Medicine.

[56]  S. Buys,et al.  The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial. , 2008, Gynecologic oncology.

[57]  Gillian D Sanders,et al.  Benefits and Harms of Breast Cancer Screening: A Systematic Review. , 2015, JAMA.

[58]  Robert Fletcher,et al.  Standardized colonoscopy reporting and data system: report of the Quality Assurance Task Group of the National Colorectal Cancer Roundtable. , 2007, Gastrointestinal endoscopy.

[59]  D. Oram,et al.  Ovarian cancer screening and mortality in the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS): a randomised controlled trial , 2016, The Lancet.

[60]  Stephen W Duffy,et al.  A breast cancer prediction model incorporating familial and personal risk factors , 2004, Hereditary Cancer in Clinical Practice.

[61]  S. Fedewa,et al.  Cancer screening in the United States, 2015: A review of current American Cancer Society guidelines and current issues in cancer screening , 2015, CA: a cancer journal for clinicians.

[62]  Amy B. Knudsen,et al.  Evaluating Test Strategies for Colorectal Cancer Screening: A Decision Analysis for the U.S. Preventive Services Task Force , 2008, Annals of Internal Medicine.

[63]  L. Tabár,et al.  Tumour development, histology and grade of breast cancers: Prognosis and progression , 1996, International journal of cancer.

[64]  D. Altman,et al.  The benefits and harms of breast cancer screening: an independent review , 2012, British Journal of Cancer.

[65]  A. Jemal,et al.  Colorectal cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[66]  P. Marcus,et al.  Use of Lung Cancer Screening Tests in the United States: Results from the 2010 National Health Interview Survey , 2012, Cancer Epidemiology, Biomarkers & Prevention.

[67]  Edward Azavedo,et al.  Guidelines for International Breast Health and Cancer Control – Implementation Supplement to Cancer Guideline Implementation for Breast Healthcare in Low-Income and Middle-Income Countries Overview of the Breast Health Global Initiative Global Summit 2007 , 2008 .

[68]  Matthew Burnell,et al.  Sensitivity and specificity of multimodal and ultrasound screening for ovarian cancer, and stage distribution of detected cancers: results of the prevalence screen of the UK Collaborative Trial of Ovarian Cancer Screening (UKCTOCS) , 2009, Journal of Family Planning and Reproductive Health Care.

[69]  J. T. Cox,et al.  American Cancer Society Guideline for Human Papillomavirus (HPV) Vaccine Use to Prevent Cervical Cancer and Its Precursors , 2007, CA: a cancer journal for clinicians.

[70]  T. Reynolds,et al.  The role of CA 125 in clinical practice , 2005 .

[71]  L. Tabár,et al.  Efficacy of breast cancer screening by age. New results swedish two‐county trial , 1995, Cancer.

[72]  J Austoker,et al.  Interventions to promote cancer awareness and early presentation: systematic review , 2009, British Journal of Cancer.

[73]  S. Stokley,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2014 , 2015, MMWR. Morbidity and mortality weekly report.

[74]  Douglas K Rex,et al.  Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. , 2012, Gastroenterology.

[75]  Peter B Cotton,et al.  Colonoscopy: practice variation among 69 hospital-based endoscopists. , 2003, Gastrointestinal endoscopy.

[76]  M. Gail,et al.  Projecting individualized probabilities of developing breast cancer for white females who are being examined annually. , 1989, Journal of the National Cancer Institute.

[77]  James M. Dahlhamer,et al.  Subunit Nonresponse in the National Health Interview Survey (NHIS): An Exploration Using Paradata , 2009 .

[78]  Patrick C. Walsh,et al.  American Cancer Society Guidelines for the Early Detection of Cancer , 2002, CA: a cancer journal for clinicians.

[79]  Aasma Shaukat,et al.  Long-term mortality after screening for colorectal cancer. , 2013, The New England journal of medicine.

[80]  B. Levin,et al.  Screening and surveillance for the early detection of colorectal cancer and adenomatous polyps, 2008: a joint guideline from the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. , 2008, Gastroenterology.

[81]  J. Lortet-Tieulent,et al.  Breast Cancer Screening for Women at Average Risk: 2015 Guideline Update From the American Cancer Society. , 2015, JAMA.

[82]  L. Walter,et al.  Screening mammography in older women: a review. , 2014, JAMA.

[83]  S. Woolf,et al.  Colorectal cancer screening and surveillance: clinical guidelines and rationale-Update based on new evidence. , 2003, Gastroenterology.

[84]  Kenneth Offit,et al.  Genetic/Familial High-Risk Assessment: Breast and Ovarian, Version 2.2015. , 2016, Journal of the National Comprehensive Cancer Network : JNCCN.

[85]  Mitchell H Gail,et al.  Comparing breast cancer risk assessment models. , 2010, Journal of the National Cancer Institute.

[86]  B. Levin,et al.  Emerging Technologies in Screening for Colorectal Cancer: CT Colonography, Immunochemical Fecal Occult Blood Tests, and Stool Screening Using Molecular Markers , 2003, CA: a cancer journal for clinicians.

[87]  Rebecca L. Siegel Mph,et al.  Cancer statistics, 2016 , 2016 .

[88]  D. Miglioretti,et al.  Mammographic screening interval in relation to tumor characteristics and false‐positive risk by race/ethnicity and age , 2013, Cancer.

[89]  Robert A Smith,et al.  Cancer Screening in the United States, 2007: A Review of Current Guidelines, Practices, and Prospects , 2007, CA: a cancer journal for clinicians.

[90]  Elizabeth R. Unger,et al.  Use of 9-Valent Human Papillomavirus (HPV) Vaccine: Updated HPV Vaccination Recommendations of the Advisory Committee on Immunization Practices , 2015, MMWR. Morbidity and mortality weekly report.

[91]  J. Hardcastle,et al.  Colorectal cancer , 1993, Europe Against Cancer European Commission Series for General Practitioners.

[92]  Emily White,et al.  Factors contributing to mammography failure in women aged 40-49 years. , 2004, Journal of the National Cancer Institute.

[93]  G. Guyatt,et al.  Grading quality of evidence and strength of recommendations , 2004, BMJ : British Medical Journal.

[94]  Elena A. Manilich,et al.  Adenoma Detection Rate: The Real Indicator of Quality in Colonoscopy , 2008, Diseases of the colon and rectum.

[95]  Rebecca A Hubbard,et al.  Outcomes of screening mammography by frequency, breast density, and postmenopausal hormone therapy. , 2013, JAMA internal medicine.

[96]  S. Stokley,et al.  National, Regional, State, and Selected Local Area Vaccination Coverage Among Adolescents Aged 13–17 Years — United States, 2017 , 2018, MMWR. Morbidity and mortality weekly report.

[97]  R Wender,et al.  American Cancer Society Guidelines for the Early Detection of Cancer: Update of Early Detection Guidelines for Prostate, Colorectal, and Endometrial Cancers: ALSO: Update 2001—Testing for Early Lung Cancer Detection , 2001, CA: a cancer journal for clinicians.

[98]  A. D'Amico,et al.  American Cancer Society Guideline for the Early Detection of Prostate Cancer: Update 2010 , 2010, CA: a cancer journal for clinicians.

[99]  Rebecca L. Siegel Mph,et al.  Colorectal cancer statistics, 2014 , 2014 .

[100]  Giovanni Parmigiani,et al.  BRCAPRO validation, sensitivity of genetic testing of BRCA1/BRCA2, and prevalence of other breast cancer susceptibility genes. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[101]  D. Faigel,et al.  The Quality of Colonoscopy Services—Responsibilities of Referring Clinicians , 2010, Journal of General Internal Medicine.

[102]  Diljeet Singh,et al.  The role of ultrasound evaluation in the detection of early-stage epithelial ovarian cancer. , 2005, American journal of obstetrics and gynecology.

[103]  A. Jemal,et al.  Cancer statistics, 2016 , 2016, CA: a cancer journal for clinicians.

[104]  Marcin Polkowski,et al.  Quality indicators for colonoscopy and the risk of interval cancer. , 2010, The New England journal of medicine.

[105]  C. Gatsonis,et al.  Reduced Lung-Cancer Mortality with Low-Dose Computed Tomographic Screening , 2012 .

[106]  D. Easton,et al.  The BOADICEA model of genetic susceptibility to breast and ovarian cancer , 2004, British Journal of Cancer.